Diet, menopause and the risk of ovarian, endometrial and breast cancer
- PMID: 30706844
- DOI: 10.1017/S0029665118002884
Diet, menopause and the risk of ovarian, endometrial and breast cancer
Abstract
Menopause, the permanent cessation of the menstrual cycle, marks the end of a woman's reproductive lifespan. In addition to changes in sex hormone levels associated with menopause, its timing is another predictor of future health outcomes such as duration of the presence of vasomotor symptoms (VMS) and the risk of hormone-related cancers. With ageing of the population, it is estimated that worldwide 1·2 billion women will be menopausal by the year 2030. Previously the effects of reproductive factors (e.g. parity, age at menarche, pregnancy) and socio-demographic factors on intermediate and long-term health outcomes of menopause have been widely documented. However, little is known about whether diet could have an impact on these. Therefore, we review current evidence on the associations of diet with menopause, presence of VMS and the risk of hormone-related cancers such as ovarian, endometrial and breast cancer. Dietary factors could influence the lifespan of the ovaries and sex-hormones levels, hence the timing of natural menopause. Few studies reported an association between diet, in particular soya consumption, and a reduced risk of VMS. Sustained oestrogen exposure has been associated with a higher risk of hormone-related cancers and thus high-fat and meat diets have been linked with an increased risk of these cancers. However, to better understand the mechanistic pathways involved and to make stronger conclusions for these relationships, further studies investigating the associations of dietary intakes and dietary patterns with menopause, presence of VMS and the risk of hormone-related cancers are required.
Keywords: AMH antimullerian hormone; ER oestrogen receptor; FA fatty acid; FSH follicle-stimulating hormone; VMS vasomotor menopausal symptoms; Breast cancer; Diet; Endometrial cancer; Onset of menopause; Ovarian cancer; Vasomotor symptoms.
Similar articles
-
Hormone replacement therapy and cancer.Gynecol Endocrinol. 2001 Dec;15(6):453-65. Gynecol Endocrinol. 2001. PMID: 11826770 Review.
-
Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.Climacteric. 2001 Sep;4(3):181-93. Climacteric. 2001. PMID: 11588941 Review.
-
Epidemiology of breast cancer.Clin Obstet Gynecol. 1982 Jun;25(2):387-92. doi: 10.1097/00003081-198206000-00021. Clin Obstet Gynecol. 1982. PMID: 7105514
-
The prevention of breast cancer through reduced ovarian steroid exposure.Acta Oncol. 1992;31(2):167-74. doi: 10.3109/02841869209088898. Acta Oncol. 1992. PMID: 1622631 Review.
-
Characterizing the trajectories of vasomotor symptoms across the menopausal transition.Menopause. 2016 Oct;23(10):1067-74. doi: 10.1097/GME.0000000000000676. Menopause. 2016. PMID: 27404029 Free PMC article.
Cited by
-
Model Predicting the Risk of Endometrial Hyperplasia Developing into Endometrial Cancer.J Inflamm Res. 2024 Sep 7;17:6159-6171. doi: 10.2147/JIR.S471620. eCollection 2024. J Inflamm Res. 2024. PMID: 39262650 Free PMC article.
-
Elucidating the roles of the mammary and gut microbiomes in breast cancer development.Front Oncol. 2023 Aug 17;13:1198259. doi: 10.3389/fonc.2023.1198259. eCollection 2023. Front Oncol. 2023. PMID: 37664075 Free PMC article. Review.
-
Occupational risk factors and breast cancer in Beijing, China: a hospital-based case-control study.BMJ Open. 2022 Feb 17;12(2):e054151. doi: 10.1136/bmjopen-2021-054151. BMJ Open. 2022. PMID: 35177451 Free PMC article.
-
Effects of Functional and Nutraceutical Foods in the Context of the Mediterranean Diet in Patients Diagnosed with Breast Cancer.Antioxidants (Basel). 2023 Oct 11;12(10):1845. doi: 10.3390/antiox12101845. Antioxidants (Basel). 2023. PMID: 37891924 Free PMC article. Review.
-
Breast cancer prevention with liquiritigenin from licorice through the inhibition of aromatase and protein biosynthesis in high-risk women's breast tissue.Sci Rep. 2023 May 30;13(1):8734. doi: 10.1038/s41598-023-34762-z. Sci Rep. 2023. PMID: 37253812 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical